Liquid biopsy provides new insights into gastric cancer

Camila Tavares Uchôa Guimarães; Nina Nayara Ferreira Martins; Kelly Cristina da Silva Oliveira; Caroline Martins Almeida; Thayanne Macedo Pinheiro; Carolina Oliveira Gigek; Sandro Roberto de Araújo Cavallero; Paulo Pimentel Assumpção; Marília Arruda Cardoso Smith; Rommel Rodríguez Burbano; Danielle Queiroz Calcagno

doi:10.18632/oncotarget.24540

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Liquid biopsy provides new insights into gastric cancer

Camila Tavares Uchôa Guimarães _, Nina Nayara Ferreira Martins, Kelly Cristina da Silva Oliveira, Caroline Martins Almeida, Thayanne Macedo Pinheiro, Carolina Oliveira Gigek, Sandro Roberto de Araújo Cavallero, Paulo Pimentel Assumpção, Marília Arruda Cardoso Smith, Rommel Rodríguez Burbano and Danielle Queiroz Calcagno

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:15144-15156. https://doi.org/10.18632/oncotarget.24540

Metrics: PDF 2341 views | HTML 3462 views | ?

Abstract

Camila Tavares Uchôa Guimarães1,*, Nina Nayara Ferreira Martins2,*, Kelly Cristina da Silva Oliveira2, Caroline Martins Almeida1, Thayanne Macedo Pinheiro2, Carolina Oliveira Gigek3,4, Sandro Roberto de Araújo Cavallero2, Paulo Pimentel Assumpção2, Marília Arruda Cardoso Smith3, Rommel Rodríguez Burbano2,5 and Danielle Queiroz Calcagno1,2

1Residência Multiprofissional em Oncologia, Hospital Universitário João de Barros Barreto, Universidade Federal do Pará, Belém, PA, Brazil

2Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, Brazil

3Disciplina de Genética, Universidade Federal de São Paulo, São Paulo, SP, Brazil

4Disciplina de Gastroenterologia Cirurgica, Universidade Federal de São Paulo, São Paulo, SP, Brazil

5Laboratório de Biologia Molecular, Hospital Ophir Loyola, Belém, PA, Brazil

*These authors contributed equally to this work

Correspondence to:

Danielle Queiroz Calcagno, email: [email protected]

Keywords: circulating tumor cells; circulating tumor DNA; circulating microRNAs; circulating long non-coding RNAs; precision medicine

Received: July 26, 2017 Accepted: December 01, 2017 Epub: February 21, 2018 Published: March 13, 2018

ABSTRACT

Liquid biopsies have great promise for precision medicine as they provide information about primary and metastatic tumors via a minimally invasive method. In gastric cancer patients, a large number of blood-based biomarkers have been reported for their potential role in clinical practice for screening, early diagnosis, prognostic evaluation, recurrence monitoring and therapeutic efficiency follow-up. This current review focuses on blood liquid biopsies' role and their clinical implications in gastric cancer patients, with an emphasis on circulating tumor cells (CTCs), circulating tumor DNA (ctDNA) and circulating non-coding RNAs (ncRNAs). We also provide a brief discussion of the potential and limitations of liquid biopsies use and their future use in the routine clinical care of gastric cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24540

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

Liquid biopsy provides new insights into gastric cancer

Abstract